Literature DB >> 2487033

Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983.

T Naessén1, R Parker, I Persson, M Zack, H O Adami.   

Abstract

Time trends from 1965 through 1983 for age-specific and age-standardized rates of first hospital admission for a proximal femur fracture were studied in the Uppsala Health Care Region, Sweden, using a centralized register for inpatient care. During the 19-year study period, 29,277 hospital admissions for a first hip fracture were recorded in this population of about 1.5 million persons. The total number of first hip fracture admissions per year increased for both sexes. Age-standardized admission rates for both cervical and trochanteric fractures increased in men (average change per year of 1.8% and 2.6%, respectively) in contrast to the decreased admission rate for cervical fractures (-1.6% per year) and a stable rate for trochanteric fractures (0.4% per year) in women. The cumulative rate of cervical or trochanteric fracture at ages 30-79 years increased 46% in men (from 42/1,000 population in 1965 to 61.5/1,000 population in 1983) in contrast to a 24% decrease in women (from 134/1,000 population in 1965 to 101.5/1,000 population in 1983). The female:male ratio of age-standardized incidence rates decreased for both types of fracture during the study period. This finding of stable or decreasing rates of hip fracture in women contrasts with the findings of most previous studies.

Entities:  

Mesh:

Year:  1989        PMID: 2487033     DOI: 10.1093/oxfordjournals.aje.a115335

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  29 in total

1.  Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women.

Authors:  H Hallström; A Wolk; A Glynn; K Michaëlsson
Journal:  Osteoporos Int       Date:  2006-05-04       Impact factor: 4.507

2.  Maternal age, exposure to siblings, and risk of amyotrophic lateral sclerosis.

Authors:  Fang Fang; Freya Kamel; Dale P Sandler; Pär Sparén; Weimin Ye
Journal:  Am J Epidemiol       Date:  2008-03-25       Impact factor: 4.897

3.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group.

Authors:  J A Kanis
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507

4.  [Incidence of femoral neck fractures in the German Federal Republic in comparison to other countries].

Authors:  A Cöster; M Haberkamp; B Allolio
Journal:  Soz Praventivmed       Date:  1994

5.  Increased risk of left sided colon cancer in patients with diverticular disease.

Authors:  T Stefánsson; A Ekbom; P Sparèn; L Påhlman
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

6.  Changing incidence and residual lifetime risk of common osteoporosis-related fractures.

Authors:  J B Lauritzen; P Schwarz; B Lund; P McNair; I Transbøl
Journal:  Osteoporos Int       Date:  1993-05       Impact factor: 4.507

7.  Alcoholism and cancer risk: a population-based cohort study.

Authors:  H O Adami; J K McLaughlin; A W Hsing; A Wolk; A Ekbom; L Holmberg; I Persson
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

8.  Prevalence of osteoporosis and incidence of hip fracture in women--secular trends over 30 years.

Authors:  Henrik G Ahlborg; Björn E Rosengren; Teppo L N Järvinen; Cecilia Rogmark; Jan-Ake Nilsson; Ingemar Sernbo; Magnus K Karlsson
Journal:  BMC Musculoskelet Disord       Date:  2010-03-11       Impact factor: 2.362

9.  Cancer risk in patients with diabetes mellitus.

Authors:  H O Adami; J McLaughlin; A Ekbom; C Berne; D Silverman; D Hacker; I Persson
Journal:  Cancer Causes Control       Date:  1991-09       Impact factor: 2.506

10.  Bone T-scores and functional status: a cross-sectional study on German elderly.

Authors:  Shoma Berkemeyer; Jochen Schumacher; Ulrich Thiem; Ludger Pientka
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.